mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.3 |